All Stories

  1. Low-intensity pulsed ultrasound therapy suppresses coronary adventitial inflammatory changes and hyperconstricting responses after coronary stent implantation in pigs in vivo
  2. Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease
  3. Prognostic impacts of Rho-kinase activity in circulating leucocytes in patients with vasospastic angina
  4. Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications
  5. Development of a novel shock wave catheter ablation system—A validation study in pigs in vivo
  6. Heart failure with mid-range left ventricular ejection fraction (HFmrEF) in the CHART-2 Study
  7. Low-energy extracorporeal shock wave therapy for promotion of vascular endothelial growth factor expression and angiogenesis and improvement of locomotor and sensory functions after spinal cord injury
  8. Beneficial effects of long-acting nifedipine on coronary vasomotion abnormalities after drug-eluting stent implantation: The NOVEL study
  9. Statins up-regulate SmgGDS through β1-integrin/Akt1 pathway in endothelial cells
  10. Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial
  11. Low-energy extracorporeal shock wave therapy promotes vascular endothelial growth factor expression and improves locomotor recovery after spinal cord injury
  12. 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities--from bench to bedside
  13. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association
  14. High-sensitivity C-reactive protein: still need for next-generation biomarkers for remote future cardiovascular events